Europlasma S.A. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 9.8 million compared to EUR 3.8 million a year ago. Net loss was EUR 12.67 million compared to EUR 9.88 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0004 EUR | 0.00% | 0.00% | -92.45% |
Apr. 25 | Environmental Performance Financing and Europlasma Announce the Signing of a New ?30 Million Financing Agreement | CI |
2023 | Europlasma: new tranche of OCEANE bonds issued | CF |
1st Jan change | Capi. | |
---|---|---|
-92.45% | 575K | |
+10.59% | 8.7B | |
+29.45% | 2.21B | |
-0.24% | 1.18B | |
+24.85% | 883M | |
-2.50% | 808M | |
-14.90% | 600M | |
+3.40% | 594M | |
-2.33% | 565M | |
-8.50% | 553M |
- Stock Market
- Equities
- ALEUP Stock
- News Europlasma
- Europlasma S.A. Reports Earnings Results for the Full Year Ended December 31, 2021